HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New transplant method offers hope for blood cancer patients
Disease control TerminatedThis study tested a new way to do bone marrow transplants for people with blood cancers like leukemia. It used a partially matched donor and a drug called cyclophosphamide after the transplant to help prevent rejection. The goal was to see if patients could survive at least 180 d…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
New drug combo aims to prevent transplant complications in blood cancer patients
Disease control TerminatedThis early-stage study tested whether adding itacitinib to standard anti-rejection drugs can safely prevent graft-versus-host disease (GVHD) in 84 blood cancer patients receiving a stem cell transplant. The main goal was to see if blood cell recovery was normal with the combinati…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 04:38 UTC